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Background: The ‘health spillover’ of patient illness on family members is important to capture in 
economic evaluation. This study compares the construct validity and responsiveness of two widely 
used health-related quality of life instruments, the EQ-5D-5L and SF-6D in capturing health spillover 
effects for family members with and without an informal care role (carers and non-carers).  
Methods:  Construct validity and responsiveness were assessed using data from a 2012 UK survey of 
the family impact of meningitis-related sequelae. Construct validity was assessed by testing 
associations between family members’ health status and variables anticipated to be associated with 
spillover effects (patient health status and informal care).  Responsiveness was assessed by testing 
associations between the longitudinal change in family members’ health status and longitudinal 
change in patient health and caring hours.  
Results: Among non-carers, both the EQ-5D-5L and the SF-6D exhibited construct validity with 10 
out of the 11 associations that were hypothesised being statistically significant on both measures. 
There was less clear evidence of responsiveness of the measures for non-carers. Among carers, the 
EQ-5D-5L exhibited greater construct validity as well as responsiveness, with respect to spillovers 
from patient health. This was evidenced by the EQ-5D-5L detecting 9 significant associations 
significant compared with 4 on the SF-6D. However, the SF-6D exhibited greater construct validity, 
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with respect to spillovers generated from informal care provision (5 associations significant 
compared with 2 on the EQ-5D-5L).  
Conclusion: Both the EQ-5D-5L and the SF-6D exhibited a degree of validity that could justify their 
use as measures of health-related quality of life spillovers on family members in economic 
evaluation. 
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INTRODUCTION  
Economic evaluations in health care aim to compare the costs and benefits of health interventions in 
order to determine whether they offer value-for-money (1). Cost-utility analysis is a common type of 
economic evaluation in health care that usually limits the assessments of the benefits of the 
intervention to health of the patients. However a cost-utility analysis should theoretically also 
include the health effects of an intervention to carers and family members of patients (2). Although 
this is rarely done at present, there is ongoing discussion in the literature advocating the regular 
inclusion of the health effects of interventions on family members in cost-utility (and cost-
effectiveness) analysis (3, 4). This is because the health of family members is also affected by 
illnesses and interventions since family members often share the negative emotional distress of an 
illness, and there is frequently a need for family members to provide emotionally and physically 
draining informal care for patients with chronic illness and disability (5). These mechanisms result in 
‘spillovers’ on family members’ physical and mental health (5, 6). By routinely including health 
spillovers, economic evaluations in health care can better guide health technology assessment 
decisions towards judgements that maximise health across patients and their family networks rather 
than for just the patients themselves (4). Notably, the Second Panel on Cost-Effectiveness in Health 
and Medicine recommended that the ‘QALYs of patients, carers and ‘other affected parties’ (such as 
non-caregiving family members) should be included in economic evaluation (7). 
The EQ-5D is the most commonly used instrument to measure the health status of patients in cost-
utility analysis in order to calculate quality-adjusted life years (QALYs), and is the recommended 
instrument for National Institute of Health and Care Excellence (NICE) technology appraisals in the 
UK (8, 9). However the EQ-5D may not be an appropriate instrument for measuring health spillovers 
of interventions on family members. Previous studies suggest that it is predominantly the mental 
health of carers and family members that suffers when a loved one is ill (10, 11). This suggests only 
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one item of the EQ-5D (‘anxiety and depression’) may be suitable to capture changes in family 
members’ health status arising from the illness of a patient (11).  
An alternative health status instrument is the SF-12 (12); this offers a slightly more detailed measure 
of the individual’s health status with many items related to an individual’s mental and psychological 
health, and also their lifestyle. Data collected from the SF-12 questionnaire can be converted into a 
SF-6D utility score to calculate Quality Adjusted Life Years (QALYs) (12). 
 
Assessing the validity of health status measures 
Instrument validation explores whether the variability in the values elicited from an instrument is 
compatible with existing knowledge about how the instrument should or is likely to vary according 
to some other observable variables (13). Health status measures that are compatible with existing 
hypotheses about how health is expected to vary according to predicting factors, may be seen to 
exhibit a high level of validity, and vice versa. There are different types of validity used in the 
psychometric assessments of health status measures; these include construct validity and 
responsiveness. The construct validity of an instrument is assessed by testing mini-theories that are 
developed to explain the relationship between the instrument and associated factors (13). 
Responsiveness is the ability of an instrument to respond to a meaningful or clinically important 
external change over time (13). 
The EQ-5D-5L and SF-6D instruments cannot be used interchangeably to measure an individual’s 
health status (14). There is substantial validity literature comparing the EQ-5D (3 level version) with 
the SF-6D among patient populations, with variable findings reported regarding the validity of the 
instruments depending on the patient population being assessed  (15-18). Although the EQ-5D and 
the SF-6D have been used in a range of studies to measure family health spillovers in different 
clinical contexts (11, 19-21), we are aware of only two studies assessing the validity of a generic 
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health instrument for measuring health spillovers (21, 22).   These studies assessed the convergent 
validity and known-groups validity of the EQ-5D-3L and SF-6D for measuring health spillovers in 
carers of sick children (21, 22). Convergent validity assesses how closely one instrument is related to 
other instruments that measure the same construct) (13). However these studies did not investigate 
instrument responsiveness, only briefly investigated construct validity, and did not explore the use 
of the measures amongst non-caring family members. This new study addresses these gaps. 
 
Research objective 
The purpose of this research is to compare the construct validity and responsiveness of the EQ-5D-5L 
and the SF-6D for capturing the health effects of patient illness on carers and ‘non-caring’ family 
members. A case study of families, post-meningitis, where a variety of physical and mental health 
problems create a range of caring contexts, is used as the basis of the study. 
 
METHODS  
The survey dataset of family members of meningitis survivors covered different aspects of the family 
member experience of living with and caring for the patient, including family member health status 
measured by the two instruments. This enabled an analysis of the EQ-5D-5L and SF-6D in terms of 
their ability to detect quality of life effects generated from caring about, and providing informal care 
for, an individual close to them with long-term impairments. A comparison is not made in this study 
about the relative scale of health effects in these two groups. 
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Long term family impact of meningitis case study 
Meningitis is an illness that usually infects young people, and especially infants. A longitudinal study 
was carried out with postal surveys administered 12 months apart (in 2012 and 2013) to the family 
members of meningitis survivors for self-completion (19). Meningitis is a condition that can result in 
a number of disabling and often life-long sequelae related to behaviour, mental and physical health 
impairment of the patient, resulting in a range of caring situations.   
In the family impact of meningitis study, 3417 potentially eligible family members of meningitis 
survivors were contacted to participate using a database held by the Meningitis Research 
Foundation (a large UK charity). This sampling frame does disproportionately focus on families at the 
more severe end of the illness spectrum. However, this meant that there were a higher number of 
cases of informal care which increased the power to examine instrument validity in caregiving family 
members. A specific power calculation was not used for the validity study as the sample size was 
determined by the requirements of the original family impact study (19). However the resulting 
sample size is consistent with other studies measuring validity (18, 23). Each potential eligible family 
member was sent two questionnaires; they were asked to complete the first and to pass on the 
second questionnaire to an additional person close to the survivor. The survey was completed by the 
family members themselves and  measured family members’ EQ-5D-5L and SF-6D scores,   carer 
wellbeing (using the Carer Experience Scale (24)), and elicited information about informal care 
provided by the family members (such as hours of care provided and whether personal care was 
provided). Also, information on the impact of meningitis on aspects of family members’ lives was 
assessed via a bespoke question enquiring whether “meningitis had no effect, a negative effect or a 
positive effect” on the family member’s life. Domains of life (finances, social life, family life, work, 
exercise and personal health) were selected based on a focus group discussion with members of the 
Meningitis Research Foundation (19) . Additionally, family members were also asked to complete a 
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section on the patient’s health. This involved family members providing a proxy report of the 
patient’s EQ-5D-5L.  
This dataset generated from the survey allowed us to not only look at family members who provide 
care, but also family members who were classified as non-carers. Non-carers can be defined as 
family members who do not provide informal care for the patient, but may nevertheless experience 
health spillover resulting from anxiety and distress from witnessing the illness of a loved one. This 
study does not aim to make a comparison of the impact of illness between carers and non-carers, 
but rather aims to assess validity within the two groups. In the analysis, ‘carers’ were distinguished 
from ‘non-carers’ if they reported spending any amount of time ‘providing care as the result of 
meningitis’ in the baseline survey. It is possible that some family members we classified as non-
carers for this study were providing care for other individuals or for meningitis survivors with non-
meningitis related conditions.  
 
General approach (caring ‘about’ and ‘for’ the patient) 
The sample used for the analysis was constrained in two ways. First, we focused on a single close 
family member for each patient, selected on the basis of the highest degree of social contact (19). 
This was done in order to eliminate correlation effects between multiple family members of the 
same patient. Second, families where the patient had made a complete recovery from meningitis 
were excluded. This was done to ensure that we only included family members where there was 
some degree of potential spillover from the meningitis sequelae or caring role. The sequelae most 
commonly reported were behavioural or emotional problems, mild or moderate learning difficulties, 
and scarring or tissue damage (19). 
Following Bobinac et al (2011), the health spillover of illness on family members can be described as 
the product of two different effects (5). The first effect is the psychological distress from ‘caring 
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about’ a loved one with an illness. The second effect is the physical and mental strain of providing 
informal care for a patient (or ‘caring for’ a patient). The tests of construct validity and 
responsiveness carried out in this study therefore reflect these two different effects; firstly testing 
associations between participants’ health status responses and a range of characteristics that reflect 
the severity of the patient’s condition (and therefore the likely strength of the ‘caring about’ 
spillover), and secondly testing associations between participants’ health status responses and 
characteristics reflecting the burden of caring for the patient.  
It was anticipated that the SF-6D would be more valid and responsive than the EQ-5D-5L in detecting 
health spillovers in family members, by detecting larger effect sizes and stronger correlation 
coefficients for the hypothesised associations. This is because the SF-6D contains more items than 
the EQ-5D-5L related to mental health and social functioning, and these items are expected to be 
particularly sensitive in detecting health spillovers in family members generated from the 
psychological and informal care burden of meningitis. 
 
Construct validity assessment  
Assessment of construct validity firstly compared the EQ-5D-5L and the SF-6D for measuring health 
spillovers generated from ‘caring about’ the patient, and secondly for spillovers from ‘caring for’ the 
patient. 
For non-carers and carers, hypotheses were tested predicting that better family member health 
status would be associated with better patient health and less negative experiences of meningitis 
illness, as observed in previous empirical studies of ‘caring about’ effects (Table 1)  (5, 10, 25-27).  
 
Table 1 here 
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For carers only, hypotheses were tested  predicting that the family member EQ-5D-5L and SF-6D 
were negatively associated with larger volumes of care provision, greater work and finance related 
pressures from caregiving and worse carer experiences, as observed in previous studies of ‘caring 
for’ effects (Table 1). The EQ-5D-5L and SF-6D were compared in terms of the effect sizes and the 
statistical significance of the associations tested for (further details in ‘Statistical analysis’ section). 
(27-41).  
 
Responsiveness analysis 
We hypothesised that over the course of 12 months, the change in family members’ EQ-5D-5L and 
SF-6D scores would be positively associated with changes in patient EQ-5D-5L scores and negatively 
associated with changes in the number of hours family members spent providing informal care. 
The responsiveness analysis of the EQ-5D-5L and SF-6D used the baseline data (from 2012) and 
follow-up data (from 2013) for family members of patients. The analysis was again split to cover the 
carers and the non-carers separately (as in the construct validity analysis), in order to investigate the 
performance of the measures in carers and non-carers. Anchor based methods were implemented 
to assess whether the EQ-5D-5L and SF-6D responded in expected directions to changes in the 
following two factors over the 12 month period(42): 
- patient EQ-5D-5L score (carers and non-carers) 
- number of hours per week spent on caring activities (assistance with daily 
living/organisational support/extra household activity) (carers only) 
The objective of an anchor-based analysis is to examine whether scores on the measure of interest 
change in the expected direction when compared with changes in the scores of a related construct 
or measure (the ‘anchor’ measure) (42, 43). Patient health status and informal care hours were 
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selected as anchors based on their conceptual relationship with family members’ quality of life. The 
anchors were sub-divided into 3 levels to indicate whether the ‘anchor’ had increased, decreased, or 
not changed in an important way over time(44). It was predicted that an important improvement in 
patient health or reduction in caring hours would be associated with a statistically significant 
increase in family members’ EQ-5D-5L and SF-6D score from baseline to follow-up assessment, and 
vice versa. An ‘important’ increase/decrease in the patient EQ-5D-5L score was determined by the 
measurement of a minimal clinically important difference (MCID) in scores between the two periods 
of at least 0.074, derived from a literature estimate of this difference (45). This estimate was 
obtained from an EQ-5D-3L study and used as a proxy for the EQ-5D-5L in this study as consistent 
with other studies (46, 47); as there are only limited empirical estimates of the EQ-5D-5L MCID 
available which vary widely from 0.051 to 0.10 (48, 49). In the absence of an agreed ‘important’ 
change in caring hours, we assumed that a change of 5 or more hours / week was important.  
 
Statistical analysis  
Spearman’s Rank Correlation coefficients were computed to assess the strength, statistical 
significance and directions of associations between the family health status measures, and ordinal 
independent variables of more than two groups including patient health status variables (EQ-5D-5L, 
EQ-VAS, mobility, self-care, usual activity, anxiety, pain), hours of care provided and Carer 
Experience Scale. The Mann-Whitney test was used to establish any statistically significant 
differences in health status between two groups within the sample, and the direction of these 
differences. The Spearman’s Rank Correlation test and Mann-Whitney test are non-parametric tests 
that only take into account the existence of a difference between two data points (i.e. how they 
rank) rather than the magnitude of the difference. This is an appropriate method for handling highly 
skewed variables- like the EQ-5D-5L and SF-6D composite scores (50). However in the tests of 
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responsiveness, t-tests were used (instead of non-parametric tests) because the changes in EQ-5D-
5L and SF-6D scores between 2012 and 2013 were approximately normally distributed. 
Assessments were also made about the magnitude of associations by calculating effect sizes 
(Cohen’s D) where independent variables consisted of two groups only, and correlation coefficients 
(Spearman’s) where independent variables were ordinal and consisted of more than two groups. 
Spearman’s rank correlation coefficients of between 0.3 and 0.5 are considered weak, between 0.5 
and 0.7 moderate and > 0.7 strong. For Cohen’s D effect sizes between 0.2 and 0.5 are considered 
small, between 0.5 and 0.8 moderate and > 0.8 large (51). The same interpretations apply for 
negative associations and effect sizes.                                                                                                                                                                                                                                              
The instruments were then compared to find out whether the EQ-5D-5L was able to capture larger 
effect sizes and stronger associations than the SF-6D, or vice versa. Only individuals that had a 
complete set of item responses for a validity test were included in the analysis. 
Participants were excluded from the study if the person they were close to had subsequently died, 
as the health losses experienced by bereaved family members are different to those experienced by 
the family members of living patients (52), and not the focus of this study. Participants were not 
excluded on the basis of whether they shared a household, or how they were related to the person 
with meningitis. 
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RESULTS 
 
3417 members of the Meningitis Research Foundation (MRF) were invited to participate in the 
original family impact of meningitis study (19). This resulted in 1587 eligible family members of 1218 
survivors (36% of family units) returning the baseline survey in 2012.   
For the present study, at baseline, 1546 (97%) family members completed the EQ-5D-5L, and 1485 
(94%) family members completed the SF-6D. 1053 family members (66% of the whole sample) 
reported being exposed to patient sequelae from meningitis at baseline, and 847 of these family 
members were included in the construct validity analysis (as they were the closest surveyed family 
member to the patient). 1022 (64%) of family members responded to the follow-up questionnaire in 
2013, and 536 of these family members were included in the responsiveness analysis. 
Table 2 documents the descriptive statistics in 2012 for the whole family member sample, and the 
carer and non-carer sub-samples used in the validity analyses. The patients receiving informal care 
for meningitis had a much worse mean health status (0.50) than the patients who did not receive 
informal care for meningitis (0.87).  
Table 2 here 
 
Construct validity  .  
Table 3 details the results for the tests of construct validity; split between non-carers and carers; and 
further split among carers between hypotheses either relating to ‘caring about’ or ‘caring for’ the 
patient, and hypotheses solely related to ‘caring for’ the patient. .  
 
Table 3 here 
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In the ‘caring about’ tests for the non-carers in Table 3, both the EQ-5D-5L and SF-6D each detected 
statistically significant associations with ten out of the eleven constructs, with all of these 
associations falling in the expected directions that were hypothesised prior to testing. Statistically 
significant associations were reported for patient health constructs, and these associations were 
below the threshold for a small effect. Moderate-to-large effect sizes were reported for constructs 
relating to the negative impact of meningitis on areas of family members’ lives. 
  
In the tests for carers either relating to ‘caring about’ or ‘caring for’ the patient,  the EQ-5D-5L  
generally detected larger effect sizes and stronger associations than the SF-6D, and more statistically 
significant associations  (nine out of eleven) than the SF-6D (4/11) .  
In the tests of carers solely related to ‘caring for’ the patient the SF-6D detected a statistically 
significant effect size or association five out of ten times,  and the EQ-5D-5L two out of ten times. 
These effect sizes were either small or below the conventional threshold of a small effect size.  For 
the variable ‘hours of care provided’, statistically significant associations (p<0.01) were detected 
using both the EQ-5D-5L and SF-6D, and both associations were below the conventional threshold 
for a small effect.  
 
Responsiveness  
This section details the results of the tests of responsiveness of the family member EQ-5D-5L and SF-
6D to clinically relevant external changes between 2012 and 2013, tested among the non-carers and 
carers separately.  
In table 4, there are no clearly observed ‘gradients’ of effect in the non-carers’ EQ-5D-5L or SF-6D 
moving between an improvement through to a decline in patient health status. This is the result of 
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there being few significant changes in the expected direction in non-carers’ health status when the 
patients’ health improved/did not change/worsened. 
Table 4 here 
.  
In Table 5, the EQ-5D-5L detects a gradient of effect in the expected direction in carer health status 
as patient health status moves from an improvement to a decline, whereas the SF-6D does not 
detect such an effect. This is evidenced by the carer EQ-5D-5L score improving by 0.04 between 
2012 and 2013 as the patients’ health improves, not changing when patients’ health does not 
change, and declining by 0.06 as patients’ health worsens (i.e. a gradient from positive change 
through to negative change, in line with patient health status change). Neither the carer EQ-5D-5L or 
the SF-6D detected a gradient of effect as caring hours moves from an increase to a decrease. 
Table 5 here 
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DISCUSSION 
This study systematically explored whether two commonly used health status measures are valid 
and responsive measures of health effects (spillovers) amongst carers and non-carers in patients’ 
family networks. The findings from the results suggest that the EQ-5D-5L and SF-6D both exhibit 
some degree of validity in measuring health spillovers of meningitis on family members. This is 
because in terms of construct validity, the scores of both instruments were frequently statistically 
associated with variables that were hypothesised to generate spillovers on family members’ health 
(particularly in the tests of construct validity among the larger non-carer sub-sample), and all the 
statistically significant relationships were found to be in the predicted directions that were 
hypothesised prior to analysis. These findings complement previous studies which found that the 
EQ-5D-3L and SF-6D demonstrated convergent validity in measuring the health status of carers of ill 
children(21, 22). The findings also complement existing validity literature which indicates that the 
EQ-5D-5L and SF-6D adequately cover relevant symptoms of anxiety and depression that affect the 
family members of sick patients (18, 21).  
Comparing the relative validity of the two instruments was made more complex by contrasting 
findings. In the carer sub-sample, the EQ-5D-5L exhibited greater construct validity by detecting 
stronger associations than the SF-6D for spillovers resulting from poor patient health (and also 
detecting an anticipated gradient in the responsiveness analysis as patients’ health declined over 
time). However the SF-6D detected more statistically significant associations than the EQ-5D-5L  for 
spillovers resulting from caring burden. It was expected that an instrument that is more socially 
oriented such as the SF-6D would be better at picking up associations relating to aspects of the 
caring situation. What was unexpected was that the EQ-5D-5L would be better than the SF-6D at 
detecting spillovers relating to patient health among the carers, particularly in terms of construct 
validity. One factor that may partially explain this result is that the EQ-5D-5L was used to measure 
17 
 
patient health status. As a result, there may some degree of greater alignment in scores obtained 
from the same instrument administered to both patients and family members, than if different 
instruments are administered.   
Some small gradients were observed in the responsiveness analysis. For instance for carers, a small 
and statistically significant health status improvement was observed where patients’ health was 
reported to have improved, and a small decline was observed in carers’ health where reported 
patients’ health also declined. Apart from this case, neither the EQ-5D-5L nor the SF-6D exhibited 
clear responsiveness to changes over the course of a year in patient health or the caring situation 
with lack of gradient of effect. This suggests a need to use a longer time period (>12 months) for 
future studies in this area. Furthermore, as the spillover effect (on the average family member) is 
likely to be a small proportion of the direct effect (53), it may be too small to be detected even when 
the changes in patient health exceeded the threshold for a clinically important difference. This was 
also evidenced in this study by the small effect sizes that were reported in the construct validity 
analysis. It is important to note in the responsiveness analysis that there was a general worsening in 
the health of family members between 2012 and 2013 that had a sizeable downward effect on all of 
the mean differences in family member health status between follow-up and baseline assessment: 
effect sizes and clinically important differences need to be interpreted with this in mind. 
One disadvantage of the SF-6D instrument from this study was that it appears to be more prone to 
missing data than the EQ-5D-5L. This may exacerbate the problem of missing data on family health 
spillovers within the context of health intervention trials, where the focus is more likely to be on 
achieving high response rates from the patients themselves. 
Even though in this study the SF-6D exhibited greater validity in detecting associations solely related 
to ‘caring for’ the patient, the EQ-5D-5L may yet be chosen for measuring family member health 
status if the EQ-5D-5L is a preferred measure for patient health. This is because it may be considered 
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inappropriate to use different health status measures to elicit patient QALYs and family member 
QALYs for subsequent aggregation in an economic evaluation (54). For instance,  this may be the 
case for economic evaluations conducted in England and Wales for NICE which recommend using  
the EQ-5D-5L for measuring the health of patients (9).   
The positive associations between patient health status and family member health status in this 
study may not be completely attributed to spillover from the patient to the family member. 
However, the previous study of the family impact of meningitis demonstrated that the positive 
association between patient health status and family member health status remains when 
controlling for a wide range of potentially confounding factors related to the characteristics of the 
two individuals and the shared environment (19). 
Aside from the choice of instrument for measuring health spillovers, there are other issues that need 
to be addressed to enable regular inclusion of health spillovers in economic evaluation, beyond the 
scope of this study. Unresolved issues are whether to include informal care costs alongside family 
member health status due to  the issue of potential double counting (55, 56), whether to include the 
health decrements of bereaved family members, and how many family members should be included 
in the analysis (4). The 2016 US Panel of Cost-effectiveness in Health and Medicine recommended 
that both carer time costs and QALYs should be included in economic evaluations (7), perhaps 
indicating they perceived only a small risk of double counting from including both (55). 
There are a number of strengths of this study. The study used a large sample of family members, and 
data completion of the surveys was generally high. This study is the first to assess the responsiveness 
of generic instruments for measuring health spillovers, and the first study to look at instrument 
validity specifically in non-carers.  
Some limitations of the study are also acknowledged. There was a relatively small sub-sample of 
informal carers (n=199) compared with non-carers (n=648) used in analysis. The analysis only related 
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to long-term effects on health of meningitis. Although meningitis is a condition that creates a wide 
range of symptoms among young individuals, and therefore a range of caring situations, the findings 
of this study may not be generalisable to other health conditions, especially where patients are older 
and care is mostly provided by spouses. Another limitation is that validity and responsiveness were 
not assessed in relation to a healthcare intervention. Further research addressing these limitations 
could be informative.  
In conclusion, both the EQ-5D-5L and SF-6D appear to be satisfactory instruments for measuring 
family members’ health status in an economic evaluation. This is because both instruments exhibit 
construct validity in capturing family member health spillovers. However further research is required 
to assess the validity and responsiveness of the instruments in capturing health spillovers generated 
from other illnesses and from health interventions. Such research will be important for determining 
whether the two instruments can be used interchangeably for family members in response to a 
clinical intervention. 
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Table 1: Hypotheses for associations between constructs and family members’ health status 
Survey variable Predicted direction of family member EQ-5D-5L or  
SF-6D change  
Variables relating to ‘caring about’ or ‘caring for’ a patient 
Patient EQ-5D-5L index score 
Patient Visual Analogue Scale (VAS) score 
Positive. Better patient health expected to be 
associated with lower psychological and care burden in 
family members thus better health  status(5, 25, 26) 
Patient EQ-5D-5L item responses 
 
Negative. Higher item response indicates worse patient 
health which is expected to be associated with worse 
family member health status (5, 26) 
Family members’ self-perceived impact of 
meningitis on areas of life*  
Negative. Negative experiences of illness on non-carers 
and carers  in these areas expected to translate to 
worse family member health status (5, 10, 26, 27) 
  
  
‘Caring for’ variables  
Hours of care provided Negative. Greater volumes of informal care provision 
expected to result in worse carer health (27-32) Shares house with patient  
Daily care for the patient  
Constant daytime supervision for patient  
Main carer for patient 
Provides majority of care  
Provides personal care/toileting for patient  Negative. Providing ADLs (assistance with daily living) is 
associated with high informal care burden and 
increased chance of carer distress, resulting in impaired 
carer health. (39-41) 
Carer Experience Scale  Positive. Higher score indicates better carer experience 
which is expected to result in better carer health (4, 28, 
33) 
Family members’ self-perceived impact of 
meningitis on a) work, b) finances. 
Negative. Informal carers frequently experience loss of 
household income and increased care costs, which can 
cause stress and impaired mental health. (27, 33, 37, 
38) 
* Areas of life measured were (1) family and relationships, (2) social life, (3) exercise, and (4) views 
on personal health  
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Table 2: Descriptive statistics for baseline sample, non-carer sample and carer sample  
Characteristic Full sample  
(n=1587) 
Non-carer  
sample (n=648) 
Carer   
sample 
(n=199) 
Family member 
Female (n, %) 
Age (years, mean (SD)) 
Health in 2012 (EQ-5D-5L, mean (SD)) 
Health in 2013 (EQ-5D-5L, mean (SD)) 
 
Survivor (patient) 
Female (n, %) 
Age (years, mean (SD)) 
Time since infection (years, mean (SD)) 
Health in 2012 (EQ-5D-5L, mean (SD)) 
Health in 2013 (EQ-5D-5L, mean (SD)) 
 
Context 
Relationship to patient (parent, n (%)) 
Lives with patient (n, %) 
Provides care for patient (n, %) 
Caring hours/week in 2012 (hours, mean (SD))  
Caring hours/week in 2013 (hours, mean (SD))  
 
 
1152 (72) 
51.1 (12.8) 
0.88 (0.16) 
0.86 (0.18) 
 
 
732 (46) 
23.3 (16.1) 
12.0 (7.3) 
0.84 (0.26) 
0.83 (0.25) 
 
 
1193 (75) 
964 (60) 
246 (15) 
3.68 (14.5) 
2.81 (11.9) 
 
 
556 (86) 
51.2 (12.1) 
0.87 (0.18) 
0.85 (0.19) 
 
 
292 (45.2) 
24.1 (16.2) 
12.3 (7.3) 
0.87 (0.19) 
0.85 (0.20) 
 
 
510 (79) 
390 (60.5) 
0 (0) 
n/a 
n/a  
 
 
166 (83.8) 
45.9 (11.9) 
0.83 (0.17) 
0.80 (0.20) 
 
 
100 (50.3) 
24.1 (20.3) 
10.4 (8.7) 
0.50 (0.35) 
0.52 (0.36) 
 
 
147 (74) 
166 (83) 
199 (100) 
28.8 (31.7) 
21.2 (27.5) 
 
Note: Carer and non-carer sample statistics presented here are only for the family members used in 
the validity analysis (that is, family members exposed to meningitis sequelae and assessed as the 
closest family member to the patient). 
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Table 3.  Effect sizes and correlation coefficients for tests of construct validity of the EQ-5D-5L and 
SF-6D for measuring spillovers  
Constructs associated with family 
member health spillover 
FAMILY MEMBER INDEX SCORES 
EQ-5D-5L (95% CI) SF-6D (95% CI) 
‘Caring about’ hypotheses for non- carer sub-sample (n=648) 
Patient EQ-5D-5L 0.22*** (0.14 to 0.29) 0.19*** (0.11 to 0.26) 
Patient VAS  0.19*** (0.11 to 0.26) 0.24*** (0.17 to 0.32) 
Patient Mobility  -0.09*    (-0.16 to -0.01) -0.04       (-0.12 to 0.04) 
Patient Self-Care  -0.14***(-0.22 to -0.06) -0.13**   (-0.21 to -0.05) 
Patient Usual activity  -0.07      (-0.15 to 0.00) -0.09*     (-0.17 to -0.01) 
Patient Anxiety  -0.23***(-0.30 to -0.15) -0.20*** (-0.28 to -0.12) 
Patient Pain  -0.18***(-0.26 to -0.10) -0.15*** (-0.23 to -0.07) 
Family life  -0.28*    (-0.48 to -0.09) -0.45*** (-0.66 to -0.26) 
Social life  -0.52***(-0.74 to -0.31) -0.56*** (-0.79 to -0.34) 
Exercise  -0.82**  (-1.11 to -0.53) -0.59*** (-0.89 to -0.30) 
Personal health  -0.95***(-1.31 to -0.59) -0.83*** (-1.29 to -0.46) 
Hypotheses for carer sub-sample related to ‘caring about’ or ‘caring for’ the patient (n=199) 
Patient EQ-5D-5L  0.26*** (0.12 to 0.39) 0.09       (-0.05 to 0.24) 
Patient VAS  0.24*** (0.10 to 0.37) 0.15*     (0.01 to 0.29) 
Patient mobility  -0.19**  (-0.32 to -0.05) -0.06      (-0.21 to 0.08) 
Patient self-care  -0.18**  (-0.32 to -0.05) -0.08      (-0.22 to 0.06) 
Patient usual activity  -0.24***(-0.38 to -0.11) -0.05      (-0.20 to 0.09) 
Patient anxiety -0.14      (-0.27 to 0.01) -0.17*    (-0.31 to -0.03) 
Patient pain -0.07      (-0.21 to 0.07) -0.03      (-0.17 to 0.11) 
Family life  -0.30*    (-0.59 to -0.01) -0.09      (-0.38 to 0.21) 
Social life  -0.45**  (-0.74 to -0.15) -0.34*    (-0.64 to -0.05) 
Exercise  -0.55***(-0.85 to -0.24) -0.48***(-0.79 to -0.18) 
Personal health  -0.88**  (-1.33 to -0.44) -0.44      (-0.88 to 0.01) 
Hypotheses for carer sub-sample solely related to ‘caring for’ the patient (n=199) 
Hours of care provided   -0.21** (-0.34 to -0.07)  -0.21** (-0.34 to -0.06) 
Carer Experience Scale   0.34***(0.19 to 0.47)  0.23**  (0.08 to 0.38) 
Shares house  -0.21      (-0.58 to 0.17) -0.06      (-0.45 to 0.32) 
Daily care  -0.04      (-0.39 to 0.32) -0.43*    (-0.80 to -0.06) 
Main carer 0.07       (-0.29 to 0.43)  -0.50*   (-0.87 to -0.12) 
Provides majority of care  -0.08      (-0.37 to 0.23) 0.12       (-0.19 to 0.42) 
Provides personal care  0.11       (-0.17 to 0.39) 0.14       (-0.13 to 0.42) 
Impact of meningitis on work -0.24      (-0.53 to 0.05) -0.35*    (-0.65 to -0.05) 
Impact of meningitis on finances  -0.13      (-0.42 to 0.18) -0.04      (-0.34 to 0.26) 
Provides constant supervision -0.10      (-0.40 to 0.20) -0.20      (-0.51 to 0.10) 
*p<0.05, **p<0.01, ***p<0.001 
§VAS- visual analogue scale   
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            §Spearman’s rank correlation coefficients of > 0.3 are considered weak associations, > 0.5 moderate, > 
0.7 strong associations. For Cohen’s D effect sizes of > 0.2 are considered small, > 0.5 moderate and > 0.8 
large. The same interpretations apply for negative correlation coefficients and effect sizes.                                                                                                                                                                                                                                                    
§ Spearman’s rho reported for all constructs which are continuous variables (patient EQ-5D-5L, VAS, mobility, 
self-care, usual activity, anxiety, pain, hours of care provided, Carer Experience Scale). Cohen’s D reported for 
all other variables.                                                                                                                          
§ Note: Higher score of patient EQ-5D-5L and VAS indicates better patient health, whereas higher score of the 
individual items of patient EQ-5D-5L indicates poorer patient health. 
§ Note: Higher score on the Carer Experience Scale indicates a better experience, hence a positive association 
with family member index scores.                                                                                                                                                                                                                           
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Table 4: Tests of responsiveness of the EQ-5D-5L and SF-6D in non-carers  
*p<0.05, **p<0.01, ***p<0.001 
§  Cohen’s D effect sizes of 0.2 to 0.5 are considered small, 0.5 moderate and > 0.8 large. 
 
  
Patient  
EQ-5D-5L 
Non-carer      
EQ-5D-5L 2012 
baseline (mean) 
Non-carer        
EQ-5D-5L 2013 
follow-up (mean) 
Difference between 
follow-up and baseline 
EQ-5D-5L (95% CI) 
Effect size 
(Cohen’s D) 
n 
Improved 0.83 0.84     0.01 (-0.02, 0.04)  0.01 46 
No change 0.91 0.88    -0.03*** (-0.04, -0.01) -0.19 234 
Worsened 0.84 0.81    -0.03** (-0.06, -0.01) -0.14 115 
 
Patient 
EQ-5D-5L 
 
Non-carer       
SF-6D 2012 
baseline (mean) 
 
Non-carer          
SF-6D  2013 
follow-up (mean) 
 
Difference between 
follow-up and baseline 
SF-6D (95% CI) 
 
Effect size 
(Cohen’s D) 
 
n 
Improved 0.76 0.76     0.00 (-0.03, 0.03) 0.00 43 
No change 0.81 0.79    -0.02** (-0.03, -0.01) -0.17 210 
Worsened 0.76 0.75    -0.01 (-0.03, 0.01) -0.05 104 
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       Table 5: Tests of responsiveness of the EQ-5D-5L and SF-6D in carers 
 Carer  
EQ-5D-5L 
2012 baseline 
(mean) 
Carer  
EQ-5D-5L 
2013 follow-
up (mean) 
Difference between 
follow-up and baseline 
EQ-5D-5L (95% CI) 
Effect size 
(Cohen’s D) 
n 
Patient EQ-5D-5L 
Improved 0.79 0.83    0.04 (-0.04, 0.13) 0.19 22 
No change 0.84 0.83    0.00 (-0.03, 0.02) -0.02 60 
Worsened 0.80 0.73   -0.06** (-0.11, -0.02) -0.27 41 
Hours of care provided  
Less care 0.80 0.77    -0.03 (-0.08, 0.01) -0.16 29 
No change 0.81 0.82     0.01 (-0.04, 0.06) 0.05 30 
More care 0.84 0.79    -0.05* (-0.10, 0.00) -0.31 23 
      
 Carer SF-6D 
2012 baseline 
(mean) 
Carer  SF-6D 
2013 follow-
up (mean) 
Difference between 
follow-up and baseline 
SF-6D (95% CI) 
Effect size 
(Cohen’s D) 
n 
Patient EQ-5D-5L 
Improved 0.71 0.70    -0.01 (-0.07, 0.06) -0.04 22 
No change 0.71 0.70    -0.01 (-0.04, 0.01) -0.12 59 
Worsened 0.69 0.65    -0.05* (-0.08, -0.01) -0.36 39 
Hours of care provided for patient  
Less care 0.68 0.66    -0.02 (-0.06, 0.03) -0.12 27 
No change 0.71 0.71     0.00 (-0.04, 0.04) -0.02 31 
More care 0.72 0.67    -0.05* (-0.10, -0.01) -0.51 21 
*p<0.05, **p<0.01, ***p<0.001 
§ Cohen’s D effect sizes of of 0.2 to 0.5 are considered small, 0.5 moderate and > 0.8 large.                                                                                                                          
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